India · Delayed Price · Currency is INR Mankind Pharma Company Description
Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products in India and internationally.
The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, gynaecology, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, respiratory diseases, etc. It also provides consumer healthcare products, such as condoms, pregnancy detection kits, oral contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations.
In addition, the company engages in the trading and exporting of pharmaceutical and health care products; manufacture of packing materials, ayurvedic products, and consumer goods; real estate, leasing, and hospitality businesses; trading of agricultural products; and provision of IT services.
It offers its products under the Manforce, Moxi Kind-Cv, AmLokind-At, Unwanted-Kit, Prega News, Dydroboon, Gudcef, Candi Force, Glimestar-M, Telmikind-Am, Nurokind-Gold, Telmikind-H, Nurokind-Lc, Telmikind, Vomikind, Cefakind, Nurokind Plus-Rf, Gudcef-Cv, Monticope, and Asthakind-Dx brand names.
Mankind Pharma Limited was incorporated in 1991 and is based in New Delhi, India.
| Country | India |
| Founded | 1991 |
| Industry | Pharmaceutical Preparations |
| Employees | 26,978 |
| CEO | Sheetal Arora |
Contact Details
Address: 262, Okhla Industrial Estate New Delhi, Delhi 110 020 India | |
| Phone | 91 11 4684 6700 |
| Website | mankindpharma.com |
Stock Details
| Ticker Symbol | 543904 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Sheetal Arora | Chief Executive Officer |
| Ashutosh Dhawan | Chief Financial Officer |
| Arjun Juneja | Chief Operating Officer |
| Abhishek Agarwal | Head of Investor Relations |